Immunoreactive gamma-melanotropin in rat pituitary and plasma: a partial characterization

Area of Science:

• Endocrinology
• Neuroscience
• Biochemistry

Background:

• Proopiomelanocortin (POMC) is a precursor protein cleaved into various bioactive peptides.
• Gamma MSH (γ-MSH) is a POMC-derived peptide with poorly understood physiological roles.
• Characterizing γ-MSH forms and their regulation is crucial for understanding pituitary function.

Purpose of the Study:

• To establish and validate a radioimmunoassay (RIA) for detecting gamma MSH (γ-MSH) in rat pituitary and plasma.
• To identify and characterize different immunoreactive forms of γ-MSH.
• To investigate the release and regulation of γ-MSH in response to physiological stimuli.

Main Methods:

• Development and validation of a RIA using an antiserum against synthetic bovine γ-MSH.
• Gel filtration chromatography to determine molecular weights of immunoreactive forms.
• Concanavalin A-agarose affinity chromatography to assess glycosylation.
• Measurement of γ-MSH in pituitary extracts and plasma under various conditions.

Main Results:

• Two heterogeneous immunoreactive (IR-) forms of γ-MSH (11K and 6K) were detected in rat pituitary and plasma.
• Both 11K and 6K forms were identified as glycosylated peptides.
• The 6K form constituted a significant portion of total IR-γ-MSH, particularly in the neurointermediate lobe.
• IR-γ-MSH release from pituitary cells was modulated by secretagogues.
• Plasma and anterior pituitary content of IR-γ-MSH and ACTH showed concordant changes with pituitary-adrenal axis perturbations.
• Plasma 6K IR-γ-MSH levels significantly increased following stress.

Conclusions:

• A validated RIA allows for the quantification of γ-MSH forms in rat biological samples.
• Two distinct glycosylated forms of γ-MSH exist in the rat pituitary and circulation.
• The 6K form of γ-MSH is released and its circulating levels are sensitive to stress and pituitary-adrenal axis activity.
• These findings provide insights into the processing and regulation of POMC-derived peptides, particularly γ-MSH.